Ausgabe 1/2017
Special Issue on Acromegaly
Inhalt (23 Artikel)
David L. Kleinberg: in memoriam
Epidemiology of acromegaly: review of population studies
Aikaterini Lavrentaki, Alessandro Paluzzi, John A. H. Wass, Niki Karavitaki
Acromegaly: clinical features at diagnosis
Lucio Vilar, Clarice Freitas Vilar, Ruy Lyra, Raissa Lyra, Luciana A. Naves
Biochemical investigations in diagnosis and follow up of acromegaly
Katharina Schilbach, Christian J. Strasburger, Martin Bidlingmaier
Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities
Rosario Pivonello, Renata S. Auriemma, Ludovica F. S. Grasso, Claudia Pivonello, Chiara Simeoli, Roberta Patalano, Mariano Galdiero, Annamaria Colao
Pathology of GH-producing pituitary adenomas and GH cell hyperplasia of the pituitary
Luis V. Syro, Fabio Rotondo, Carlos A. Serna, Leon D. Ortiz, Kalman Kovacs
Somatostatin and dopamine receptor regulation of pituitary somatotroph adenomas
Anat Ben-Shlomo, Ning-Ai Liu, Shlomo Melmed
Somatostatin receptor ligands in the treatment of acromegaly
Monica R. Gadelha, Luiz Eduardo Wildemberg, Marcello D. Bronstein, Federico Gatto, Diego Ferone
Somatostatin receptor ligands in acromegaly: clinical response and factors predicting resistance
Rosa Maria Paragliola, Salvatore Maria Corsello, Roberto Salvatori
T2-weighted MRI signal intensity as a predictor of hormonal and tumoral responses to somatostatin receptor ligands in acromegaly: a perspective
Iulia Potorac, Albert Beckers, Jean-François Bonneville
Pegvisomant: a growth hormone receptor antagonist used in the treatment of acromegaly
Nicholas A. Tritos, Beverly M. K. Biller
The role of combination medical therapy in the treatment of acromegaly
Dawn Shao Ting Lim, Maria Fleseriu
Management of aggressive growth hormone secreting pituitary adenomas
Daniel A. Donoho, Namrata Bose, Gabriel Zada, John D. Carmichael